Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AnHorn Medicines logo — Innovation to New Therapeutics - New Opportunities to Target...

AnHorn Medicines

Innovation to New Therapeutics - New Opportunities to Target Difficult-to-treat Diseases

Founded 2020 Taiwan Taiwan 12 employees Health and Wellness

General Information

Company Name AnHorn Medicines
Founded Year 2020
Location Taiwan Taiwan +1
Employees 12
Industries Health and Wellness
Social

Get notified when AnHorn Medicines moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AnHorn Medicines

AnHorn Medicines, established in 2020, is an innovative player in the Health and Wellness industry, headquartered in Taiwan. The company is carving out a niche by focusing on the discovery of new therapeutics aimed at targeting and degrading disease-related proteins.

Driven by their proprietary BIGPRO® (Bi-functional liGand induced PROteolysis) platform, AnHorn Medicines is pushing the envelope in Targeted Protein Degradation (TPD), a promising approach for tackling intractable diseases. Their primary focus covers a spectrum of critical areas, including cancer, neurodegeneration, and aging diseases, where drug resistance often poses significant treatment challenges.

Despite not having publicly received recent investment, AnHorn Medicines represents a compelling opportunity, particularly for venture capitalists interested in innovative biotech solutions with the potential for substantial impact in high-demand therapeutic areas.

Taxonomy: Drug Discovery, Targeted Protein Degradation, Bi-functional Ligand Technology, Cancer Therapeutics, Neurodegenerative Disease Treatment, Aging-related Disease Therapy, Protein Degradation Technologies, Disease-related Protein Targeting, BIGPRO Technology, Resistance Overcoming Drugs, Advanced Therapeutics Development, Innovative Drug Pipeline, Proteolysis Targeting, Disease-specific Protein Degradation, Biotech Innovation

Services & Products

Drug Discovery and Development
AI-Driven Therapeutics
Biopharmaceutical Research

Target Customers

Healthcare Providers Pharmaceutical Partners Patients with Neurological Disorders Patients with Cancer Organizations in Prescription Aesthetics

No funding data available for AnHorn Medicines yet.

Get notified when AnHorn Medicines raises funding

AnHorn Medicines Alternatives & Competitors

AnHorn Medicines vs
TRIANA Biomedicines
TRIANA Biomedicines

A venture-backed biopharmaceutical company dedicated to discovering and developing novel therapeutic...

AnHorn Medicines vs
Kineta (Reverse Merger With Yumanity Therapeutics)
Kineta (Reverse Merger With Yumanity Therapeutics)

Pioneering new horizons in neurodegenerative disease treatment by addressing protein misfolding.

Series Unknown
Biotechnology, Health Care
AnHorn Medicines vs
Senexis Limited
Senexis Limited United Kingdom

Small-molecule therapies targeting amyloid protein toxicity

Unknown
3 employees
Biotechnology, Life Sciences
Also compare with: AnHorn Medicines vs Captor Therapeutics SA Captor Therapeutics SA AnHorn Medicines vs Halda Therapeutics Halda Therapeutics

FAQ About AnHorn Medicines

Innovation to New Therapeutics - New Opportunities to Target Difficult-to-treat Diseases
AnHorn Medicines was founded in 2020.
AnHorn Medicines is headquartered in Taiwan.
AnHorn Medicines operates in the following industries: Health and Wellness.
AnHorn Medicines has approximately 12 employees.
AnHorn Medicines offers: Drug Discovery and Development, AI-Driven Therapeutics, Biopharmaceutical Research.
Top alternatives and competitors to AnHorn Medicines include TRIANA Biomedicines, Kineta (Reverse Merger With Yumanity Therapeutics), Senexis Limited, Amyl Therapeutics, Captor Therapeutics SA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AnHorn Medicines and TRIANA Biomedicines are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AnHorn Medicines and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes